Moin A Saleem Selected Research

Zinc Finger E-box Binding Homeobox 2

1/2019	Hypoxia induces ZEB2 in podocytes: Implications in the pathogenesis of proteinuria.
1/2016	Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moin A Saleem Research Topics

Disease

33	Proteinuria 01/2022 - 06/2002
28	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2022 - 10/2002
18	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 08/2005
11	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2021 - 01/2006
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 12/2003
8	Albuminuria 01/2017 - 11/2005
7	Wilms Tumor (Wilm's Tumor) 11/2020 - 06/2010
7	Neoplasms (Cancer) 11/2020 - 01/2009
6	Kidney Diseases (Kidney Disease) 12/2021 - 04/2012
5	Infections 07/2022 - 01/2009
5	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 02/2021 - 11/2008
5	Glomerulonephritis 01/2019 - 10/2007
5	Renal Insufficiency (Renal Failure) 11/2018 - 03/2009
4	Respiratory Tract Infections (Respiratory Tract Infection) 07/2022 - 04/2014
4	Hyperglycemia 07/2021 - 12/2012
4	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 02/2016 - 09/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2006
3	Hypoxia (Hypoxemia) 01/2019 - 08/2014
3	Chronic Renal Insufficiency 01/2018 - 01/2010
3	Hypertension (High Blood Pressure) 01/2017 - 11/2004
3	Insulin Resistance 12/2015 - 11/2005
3	Pre-Eclampsia (Preeclampsia) 12/2013 - 08/2011
3	Fabry Disease (Fabry's Disease) 01/2013 - 01/2011
2	Epilepsy (Aura) 01/2021 - 01/2017
2	Disease Progression 01/2021 - 01/2016
2	Hemorrhage 01/2019 - 12/2010
2	Hypertrophy 01/2017 - 01/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 07/2015
2	Fibrosis (Cirrhosis) 01/2016 - 06/2010
2	Obesity 01/2016 - 01/2016
2	Lupus Nephritis 10/2014 - 04/2009
2	Necrosis 05/2012 - 01/2009
2	Inflammation (Inflammations) 01/2011 - 06/2002
2	Nephritis 04/2009 - 11/2007
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2009 - 04/2008
1	Virus Diseases (Viral Diseases) 01/2022
1	Hantavirus Infections 01/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2022
1	Neuroblastoma 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 11/2020
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 01/2020

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 11/2022 - 12/2003
14	nephrinIBA 11/2021 - 10/2002
9	NPHS2 proteinIBA 01/2022 - 10/2002
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 06/2003
7	Messenger RNA (mRNA)IBA 01/2020 - 01/2009
5	SteroidsIBA 01/2019 - 11/2004
5	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2012
4	Prednisolone (Predate)FDA LinkGeneric 07/2022 - 04/2014
4	CytokinesIBA 09/2017 - 01/2009
4	Insulin (Novolin)FDA Link 12/2015 - 11/2005
3	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2013
3	Pharmaceutical PreparationsIBA 11/2020 - 10/2005
3	Puromycin AminonucleosideIBA 01/2020 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2013
3	CreatinineIBA 01/2016 - 11/2007
3	TRPC6 Cation ChannelIBA 12/2015 - 04/2009
3	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2015 - 06/2011
3	GalactosidasesIBA 01/2013 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2016
2	Bile Acids and Salts (Bile Acids)IBA 11/2020 - 01/2016
2	Zinc Finger E-box Binding Homeobox 2IBA 01/2019 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2019 - 05/2011
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2016
2	AlbuminsIBA 01/2018 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 06/2010
2	Interleukin-13IBA 09/2017 - 03/2015
2	Protein Isoforms (Isoforms)IBA 01/2017 - 12/2015
2	Small Interfering RNA (siRNA)IBA 10/2016 - 08/2010
2	LipopolysaccharidesIBA 02/2016 - 03/2009
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 06/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 11/2009
2	Transcription Factors (Transcription Factor)IBA 09/2015 - 12/2012
2	Extracellular Matrix ProteinsIBA 09/2015 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 06/2002
2	LigandsIBA 10/2014 - 04/2009
2	IntegrinsIBA 10/2014 - 10/2005
2	Shiga Toxin 2IBA 05/2014 - 03/2009
2	GlycosphingolipidsIBA 01/2013 - 06/2011
2	Streptozocin (Streptozotocin)FDA Link 05/2012 - 01/2012
2	AngiotensinsIBA 01/2012 - 05/2010
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2011 - 03/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 04/2008
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Dynamin IIIBA 01/2022
1	heparanaseIBA 01/2022
1	nintedanibIBA 12/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 07/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2021
1	Interleukin-4 (Interleukin 4)IBA 02/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Inositol Polyphosphate 5-PhosphatasesIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	GlucocorticoidsIBA 01/2020
1	Cathepsin CIBA 01/2020

Therapy/Procedure

5	Transplantation 11/2021 - 12/2012
5	Therapeutics 01/2019 - 01/2006
3	Kidney Transplantation 01/2020 - 05/2011